Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
The Urologic Clinics of North America
|
February 1, 1991
Total androgen ablation: European experience. The EORTC GU Group
L Denis, P Smith, J L Carneiro de Moura, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer
L Denis, F Keuppens, C Mahler, et al.
European Urology
|
January 1, 1990
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group
L Denis, P H Smith, J L De Moura, et al.
The Journal of Urology
|
October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma
F M Debruyne, L Denis, G Lunglmayer, et al.
Clinical Endocrinology
|
December 24, 1997
Two years of replacement therapy in adults with growth hormone deficiency
J Verhelst, R Abs, M Vandeweghe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 11, 2018
TSPO PET with [<sup>18</sup>F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis
Marcus Unterrainer, C Mahler, L Vomacka, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 15, 1999
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients
J Verhelst, R Abs, D Maiter, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
The Urologic Clinics of North America
|
February 1, 1991
Total androgen ablation: European experience. The EORTC GU Group
L Denis, P Smith, J L Carneiro de Moura, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer
L Denis, F Keuppens, C Mahler, et al.
European Urology
|
January 1, 1990
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group
L Denis, P H Smith, J L De Moura, et al.
The Journal of Urology
|
October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma
F M Debruyne, L Denis, G Lunglmayer, et al.
Clinical Endocrinology
|
December 24, 1997
Two years of replacement therapy in adults with growth hormone deficiency
J Verhelst, R Abs, M Vandeweghe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 11, 2018
TSPO PET with [<sup>18</sup>F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis
Marcus Unterrainer, C Mahler, L Vomacka, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 15, 1999
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients
J Verhelst, R Abs, D Maiter, et al.
Page
of 12